Physician profile
Edward K Nomoto
NPI 1861683245
$439,590.82
in general payments reported to CMS, 2019-2025
33 companies · $95K in 2025
The $95K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $14K · 2021: $47K · 2022: $79K · 2023: $81K · 2024: $100K · 2025: $95K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $179K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $48K · Consulting Fee: $28K · Travel and Lodging: $11K · Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $178,826.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,449.50 |
| Consulting Fee | $27,990.00 |
| Travel and Lodging | $10,602.39 |
| Food and Beverage | $10,025.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $185,854.45 | 2023-2025 | Meridian, Physio-Stim, Mariner Mis Tlif Retractor |
| Medtronic, INC. | $123,805.52 | 2021-2025 | Mazor X System, Pivox Oblique Lateral Spinal System, Stealthstation S8 Platform |
| Seaspine Orthopedics Corporation | $52,603.77 | 2019-2022 | |
| Globus Medical, INC. | $29,989.12 | 2023-2025 | Si-Lok, Rise-L . Rise-L A/L, Excelsiusgps Robotic Navigation System |
| Nuvasive, INC. | $19,186.47 | 2020-2023 | Xlif, Reline, Tlif |
| Medical Device Business Services, INC. | $8,554.80 | 2022 | |
| Alphatec Spine, INC | $4,298.99 | 2020-2025 | Other - Miscellaneous, Invictus Mis, Lif |
| Medtronic USA, INC. | $2,357.81 | 2019-2020 | |
| Si-Bone, INC. | $2,176.30 | 2022-2023 | |
| Clariance, INC. | $1,945.73 | 2022-2024 | Erisma-Lp Mis |
| Centinel Spine, LLC | $1,807.73 | 2019-2025 | Prodisc L |
| Depuy Synthes Sales INC. | $1,174.32 | 2019-2022 | |
| Medacta USA, INC. | $1,134.48 | 2021-2022 | |
| Kyocera Medical Technologies, INC. | $993.66 | 2024 | |
| Mml US, INC. | $636.95 | 2022-2023 | Reactiv8 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curiteva, INC. | $472.08 | 2023-2025 | |
| Integrity Implants INC. | $452.22 | 2019-2022 | |
| Zimvie INC. | $447.62 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $428.39 | 2022-2023 | Vital, Virage, Mobi-C |
| Kuros Biosciences USA, INC | $285.55 | 2021-2022 | |
| Baxter Healthcare | $204.76 | 2022 | |
| Innovasis INC | $145.30 | 2023 | |
| Spineart USA INC | $133.13 | 2019 | |
| Amplify Surgical, INC. | $106.32 | 2023 | Dualportal |
| Smith+Nephew, INC. | $73.73 | 2024-2025 | Na, Bone Anchors With Arthroscopic Delivery System, Coblation |
| Biocomposites INC | $73.06 | 2023 | Stimulan |
| Misonix INC | $58.55 | 2019-2020 | |
| Circinus Medical Technology LLC | $57.91 | 2024 | Bolt Navigation |
| Augmedics INC. | $48.41 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $30.66 | 2025 | |
| Radius Health, INC. | $21.82 | 2019 | |
| Highridge Medical LLC | $15.86 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Intrinsic Therapeutics | $15.35 | 2025 | Barricaid Acd (Annular Closure Device) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Nomoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.